“…(a) One-way analysis of variance (ANOVA) between lifetime nonsmokers, current smokers, and former smokers; green diamonds vertically centered on mean spanning 1 SD; horizontal width proportional to sample size; mean CT as follows: nonsmokers, 181±65, n ¼ 80; current smokers, 147±61, n ¼ 10; former smokers, 149 ± 64 mm, n ¼ 57; P ¼ 0.011; (b) Two-sample t-test subgroup analysis of patients with drusen or early AMD; mean CT is as follows: nonsmokers, 146 ± 46 mm, n ¼ 49; history of smoking, 121 ± 41 mm, n ¼ 49; P ¼ 0.006. exposure. 41 Smoking appears to impair endothelial cell function in many vascular regions, and evidence supports long-term vasoconstriction and altered endothelial response 37,42,43 to various vasoactive mediators in tobacco smoke. 40,44,45 Human studies indicate abnormal choroidal vascular reactivity to carbogen (high oxygen) inhalation in chronic smokers.…”